Streamex Corp. — Director's Dealing 2023

Feb 17, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioSig Technologies, Inc. (BSGM)
CIK: 0001530766
Period of Report: 2023-02-16

Reporting Person: BUHALY STEVEN J (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-16	Stock Option (Right to Buy)	$1.25	A	250000	Acquired	2033-02-15	Common Stock (250000)	Direct

Footnotes

F1: The stock options shall have a quarterly vesting schedule and shall become exercisable as of the date they vest, subject to the terms and conditions of the BioSig Technologies, Inc. 2023 Long-Term Incentive Plan and the stock option agreement by and between the Company and the reporting person.